Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug 14;13(2):956-961.
doi: 10.1159/000509074. eCollection 2020 May-Aug.

Male Breast Carcinoma after Irradiation and Long-Term Phenothiazine Exposure: A Case Report

Affiliations
Case Reports

Male Breast Carcinoma after Irradiation and Long-Term Phenothiazine Exposure: A Case Report

Ragnar Hultborn et al. Case Rep Oncol. .

Abstract

We present a young male patient with breast cancer having several risk factors likely acting in consort: irradiation of the breast for gynecomastia in adolescence and a life-long administration of phenothiazine for schizophrenia from the age of 16 years, with elevated serum prolactin level resulting in breast cancer development 24 years after irradiation.

Keywords: BRCA1; Hyperprolactinemia; Irradiation; Male breast cancer; Phenothiazine; Schizophrenia.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest from any of the authors.

Figures

Fig. 1
Fig. 1
Timeline showing the consecutive events during the patient's life.
Fig. 2
Fig. 2
Invasive ductal carcinoma. HE. ×200 (top left). Androgen receptor immunostaining, ×200 (top right). Progesterone receptor immunostaining, ×200 (middle left). Ki-67 proliferation marker immunostaining, ×200 (middle right). HercepTest for HER2 immunostaining (score 0), ×200 (bottom left). Local recurrence of invasive ductal carcinoma in musculus pectoralis major, ×40 (autopsy material; bottom right).

Similar articles

References

    1. Fentiman I. Male Breast Cancer. Springer International Publishing AG; 2017.
    1. Ormandy CJ, Hall RE, Manning DL, Robertson JF, Blamey RW, Kelly PA, et al. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. J Clin Endocrinol Metab. 1997;82((11)):3692–9. - PubMed
    1. Ji J, Sundquist K, Ning Y, Kendler KS, Sundquist J, Chen X. Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. Schizophr Bull. 2013;39((3)):527–36. - PMC - PubMed
    1. Chou FH, Tsai KY, Su CY, Lee CC. The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res. 2011;129((2–3)):97–103. - PubMed
    1. Grinshpoon A, Barchana M, Ponizovsky A, Lipshitz I, Nahon D, Tal O, et al. Cancer in schizophrenia: is the risk higher or lower? Schizophr Res. 2005;73((2–3)):333–41. - PubMed

Publication types